PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40124C00102LH and — Kaiva Strategies, LLC

Kaiva Strategies, LLC holds $90.5M across 68 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: 8(a). PoP ended Aug 18, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Kaiva Strategies, LLC

Recipient

Aug 18, 2025

PoP end

$174K

Obligated

$753K

Potential

541611

NAICS

R408

PSC

8(a)

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

8(a)

Contract number75F40124C00102

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentKaiva Strategies, LLC

CAGE99AZ4

UEIHCWKVFGBPA64

NAICS541611

PSCR408

Place of performanceIVINS UT

Pricing typeLabor Hours

Extent competedNot Available For Competition

Related solicitation75F40124R00168

PoP startAug 19, 2024

PoP end (current)Aug 18, 2025

PoP end (w/ options)Aug 18, 2027

Obligated$174K

Current value$174K

Potential value$753K

DIRECT 8(A) AWARD OF A 1-YEAR BASE PERIOD AND TWO (2) OPTION PERIODS, LABOR-HOUR (LH) STAND-ALONE CONTRACT FOR PROFESSIONAL SERVICES SUPPORT FOR CENTER FOR DRUG EVALUATION AND RESEARCH (CDER). is a federal 8(a) award for Fda Office Of Acq Grant Svcs held by Kaiva Strategies, LLC. Estimated value $753K ($174K obligated). Current period of performance ends Aug 18, 2025 (potential Aug 18, 2027). Last award drew 1 bidder. Place of performance: IVINS UT. Related solicitation 75F40124R00168.

DIRECT 8(A) AWARD OF A 1-YEAR BASE PERIOD AND TWO (2) OPTION PERIODS, LABOR-HOUR (LH) STAND-ALONE CONTRACT FOR PROFESSIONAL SERVICES SUPPORT FOR CENTER FOR DRUG EVALUATION AND RESEARCH (CDER).

Recompete timing

Public

● Past PoP end (409 days ago)

Current PoP ended Aug 18, 2025 (409 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75F40124C00102? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Kaiva Strategies, LLC — $90.5M obligated across 68 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$90.5M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75D30123C16177

NCSTLTPHIW PUBLIC HEALTH INFRASTRUCTURE SUPPORT

$29.0M

Jan 23, 2027

75F40124C00053

TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONA…

$1.9M

May 12, 2027

75F40124C00063

DIRECT 8(A) AWARD OF 3-YEAR, LABOR HOUR TYPE CONTRACT TO KAIVA STRATEGIES, LLC TO PROVIDE …

$653K

Jun 13, 2027

75F40126F19027

CDER OPQ TEMPORARY PROFESSIONAL SERVICES EO 14398

$249K

Jun 21, 2027

75F40124C00092

DIRECT 8(A) AWARD OF 3-YEAR, TIME & MATERIALS TYPE CONTRACT TO KAIVA TO PROVIDE TPLC ADVIS…

$2.8M

Sep 11, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40124C00102?

75F40124C00102 (LH and) is a Fda Office Of Acq Grant Svcs award with a potential value of $753K, currently held by Kaiva Strategies, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40124C00102?

Fda Office Of Acq Grant Svcs awarded 75F40124C00102 to Kaiva Strategies, LLC (potential $753K).

Who is the incumbent on 75F40124C00102?

Kaiva Strategies, LLC is the incumbent with $90.5M across 68 related awards in SCOUT’s public footprint. The current period of performance ends Aug 18, 2025.

When does Kaiva Strategies, LLC’s 75F40124C00102 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 18, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40124C00102? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 13, 2025